Today's Pre-Market Movers and Top Ratings | NVDA, NFLX, AAPL, AXP and More

$NVIDIA (NVDA.US)$ 's shares increased by 1% after receiving a positive adjustment from Bank of America, which raised its earnings forecasts for 2025 and 2026. The financial institution highlighted Nvidia's significant market opportunity, which it now values at over $400 billion.

$Netflix (NFLX.US)$ experienced a 6.3% rise in its stock value after reporting quarterly earnings that surpassed predictions, with a notable addition of 5.07 million subscribers in its third quarter. This growth indicates a strategic pivot towards emphasizing profitability over rapid expansion in subscriber numbers.

$Apple (AAPL.US)$ saw its stock go up by 1.9% following reports from Counterpoint Research that sales of its latest iPhone models in China saw a 20% jump in the first three weeks when compared to last year's launch.

$Intuitive Surgical (ISRG.US)$ 's stock climbed over 6.4% following a strong third-quarter performance, where the company surpassed expectations on both revenue and earnings. The developer of the da Vinci surgical robot reported earnings of $1.84 per share and revenue of $2.04 billion. This exceeded the forecasts by analysts who had anticipated earnings of $1.63 per share on revenue of $2 billion.

$American Express (AXP.US)$ reported a 2.9% fall in its stock after the company's third-quarter earnings fell below expectations and it set aside more funds for potential credit losses, despite an increase in card usage that led to a higher full-year earnings forecast.

$Procter & Gamble (PG.US)$ saw a 0.5% decrease in share price following its report of sales below forecasts for the first quarter. The downturn was attributed to shoppers in its largest markets, the U.S. and China, opting for more affordable brands of household and personal care products.

$Tesla (TSLA.US)$ 's stock slightly declined by 0.5% on news that the National Highway Traffic Safety Administration has launched an investigation covering 2.4 million of its vehicles.

$CVS Health (CVS.US)$ 's shares tumbled by 11.4% after the company released preliminary third-quarter results that did not meet expectations and announced changes at the executive level.